Products
Omet Pharma started selling prescription medicine in 2022. Currently Omet Pharma has a portfolio of prescription medicines in oncology, respiratory, CVS and CNS for the Nordic market.
We are building a portfolio in prescription medicine
The initial focus of Omet Pharma is prescription medicine covered by tenders. These products can effectively be commercialised by an experienced and small commercial team; like the Omet Pharma team.
Branded generics and value-added medicine
Beyond 2023, branded generics and value-added medicine, will be added to the scope of Omet Pharma.